Advertisement
week in cancer news
  • September 17: The Week in Cancer News

    An immunotherapy combination continues to be effective in treating kidney cancer patients, and the FDA approves a therapy for a type of lung cancer.

    by Kevin McLaughlin

  • September 10: The Week in Cancer News

    9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers

    by Marci A. Landsmann

  • September 3: The Week in Cancer News

    Researchers investigate how antibiotics might increase the risk of colon cancer, and the FDA approves a treatment for Waldenström macroglobulinemia.

    by Bradley Jones

  • August 27: The Week in Cancer News

    Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.

    by Bradley Jones

  • August 20: The Week in Cancer News

    Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

    by Marci A. Landsmann

  • August 13: The Week in Cancer News

    Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

    by Kevin McLaughlin

  • August 6: The Week in Cancer News

    The father of a child diagnosed with brain cancer calls for better financial support for families, and a task force aims to find out more about AYA patients' quality of life.

    by Bradley Jones

  • July 30: The Week in Cancer News

    Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

    by Marci A. Landsmann

  • July 23: The Week in Cancer News

    Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.

    by Kevin McLaughlin

  • July 16: The Week in Cancer News

    A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.

    by Bradley Jones